Eterna Therapeutics Inc. Quarterly Goodwill in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Eterna Therapeutics Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q3 2024.
  • Eterna Therapeutics Inc. Goodwill for the quarter ending September 30, 2024 was $2.04M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.04M $0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.04M $0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.04M $0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.04M $0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.04M $0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.04M $0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $2.04M $0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.04M $0 0% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.04M +$253 +0.01% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.04M +$253 +0.01% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.04M +$253 +0.01% Mar 31, 2022 10-Q 2022-07-01
Q4 2021 $2.04M $0 0% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $2.04M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.04M Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $2.04M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.04M +$1.35M +194% Dec 31, 2020 10-K/A 2022-07-01
Q4 2019 $696K +$29K +4.35% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $687K -$289K -29.6% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $695K -$260K -27.2% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $681K -$297K -30.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $667K -$337K -33.6% Dec 31, 2018 10-K 2020-03-19
Q3 2018 $976K -$36K -3.56% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $955K -$13K -1.34% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $978K +$32K +3.38% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $1M +$67K +7.15% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $1.01M +$53K +5.53% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $968K -$5K -0.51% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $946K -$26K -2.68% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $937K +$28K +3.08% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $959K +$19K +2.02% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $973K -$47K -4.61% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $972K -$25K -2.51% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $909K -$175K -16.1% Dec 31, 2015 10-K 2017-03-09
Q3 2015 $940K -$190K -16.8% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $1.02M -$161K -13.6% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $997K -$142K -12.5% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $1.08M -$95K -8.06% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $1.13M -$92K -7.53% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $1.18M -$16K -1.34% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1.14M -$99K -8% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $1.18M -$86K -6.8% Dec 31, 2013 10-K 2015-03-27
Q3 2013 $1.22M -$59K -4.61% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $1.2M -$33K -2.68% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $1.24M -$26K -2.06% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $1.27M +$29K +2.35% Dec 31, 2012 10-K 2014-03-31
Q3 2012 $1.28M +$60K +4.91% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $1.23M -$61K -4.73% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $1.26M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $1.24M -$25K -1.98% Dec 31, 2011 10-K 2013-03-29
Q3 2011 $1.22M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $1.29M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 $1.26M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.